ArticleAAPS PharmSciTech2025
Evaluating 3D-Printed Pre-separator Inserts in a Fast Screening Impactor for Physicochemical Characterization of Fine Particle Dose Release from Dry Powder Inhalers.
Article in AAPS PharmSciTech, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is growing demand for simplified collection of the fine particle dose (FPD, mass of particles less than 5 µm in diameter) of orally inhaled drug products (OIDPs) for physicochemical characterization. Dissolution kinetics of the FPD are of particular interest in quality control, bioequivalence studies, and the development of branded and generic OIDPs. The Fast Screening Impactor (FSI) is an abbreviated impactor for collecting the FPD of OIDPs, but there is concern that the FSI overrepresents the FPD due to particles larger than the cutoff traveling past the impactor stage. This issue is most observable when testing dry powder inhalers (DPIs) due to their common use of coarse carrier particles. In this work, we evaluated design modifications to the pre-separator inserts of the FSI to determine their effect on the FPD collection from a commercially available DPI. 3-dimensional (3D) printed FSI inserts were designed to improve impactor cutoff efficiency and collect a FPD equivalent to that collected using full-resolution cascade impactors. Modified FSI inserts were 3D-printed with the nozzle length (T) and baseplate-to-nozzle distance (S) varied while keeping other design parameters, including nozzle diameter (D), the same as the manufacturer's specifications to determine the impact of design parameters on impactor cutoff efficiency. We found that increasing the T/D ratio to 1.0 showed little cutoff improvement for the standard pre-separator insert but decreasing the S/D ratio to 1.0 improved the impactor cutoff characteristics of the FPD insert, designed for a 5 µm cutoff at a 60 L/min flowrate. Our improved 3D-printed FPD insert collected an FPD that more closely matched the Anderson Cascade Impactor (ACI) and the Next Generation Impactor (NGI) FPD results. This work evaluated key design parameters necessary for improving the cutoff efficiency of pre-separator inserts to collect FPD more accurately when compared to full-resolution cascade impactors.
Indexed as
Identifiers
40739372What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.